Acasti Pharma (GRCE) Earnings (2019 - 2026)
Acasti Pharma (GRCE) earnings from Jun 30, 2019 to Mar 31, 2026. The TTM Acasti Pharma (GRCE) earnings is -$7.79M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Acasti Pharma (GRCE) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -18.51% |
| 3 Years TTM | -43.16% |
| 5 Years TTM | -16.93% |
| All Time TTM | -16.08% |
Annual Earnings change of Acasti Pharma (GRCE)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$7.79M | -18.60% |
| 2025 | -$9.57M | -25.53% |
| 2024 | -$13M | -69.71% |
| 2023 | -$42M | +332.08% |
| 2022 | -$9.82M | -50.10% |
| 2021 | -$20M | -22.85% |
| 2020 | -$26M | -35.20% |
| 2019 | -$39M | +83.12% |
| 2018 | -$22M | +2692.21% |
| 2017 | -$770K | -87.82% |
| 2016 | -$6.32M | N/A |
Comparison Acasti Pharma (GRCE) five years earnings CAGR with competitors
Acasti Pharma (GRCE) five years earnings CAGR is -16.91%.